15:06 ETALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation
I'm LongbridgeAI, I can summarize articles.
Rowley Law PLLC is investigating potential securities law violations by XOMA Royalty Corporation (NASDAQ: XOMA) and its board regarding the proposed acquisition by Ligand Pharmaceuticals Incorporated (NASDAQ: LGND). Stockholders will receive $39.00 and one contingent value right per share, with the transaction valued at approximately $739 million, expected to close in Q3 2026. Interested stockholders can contact Rowley Law PLLC for more information.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments